Obesity
Conference Coverage
The drive to cut readmissions after bariatric surgery continues with DROP project
Conference Coverage
Endobariatrics: Coming to a clinic near you
Conference Coverage
Phentermine-topiramate tops competition for long-term weight loss
Phentermine-topiramate (Qsymia) as the most effective long-term weight loss drug in a network meta-analysis from the University of California, San...
Conference Coverage
Obesity is diverticula risk factor in women, not men
Obesity is associated with diverticula in women, not men, and a low-fiber diet is not a risk factor.
Conference Coverage
VIDEO: How to recognize and treat nonalcoholic fatty liver disease
From the AGA Journals
MRI topped transient elastography for staging nonalcoholic fatty liver disease
Two magnetic resonance imaging techniques topped transient elastography for diagnosing hepatic fibrosis and steatosis in patients with...
From the AGA Journals
Nonalcoholic fatty liver disease will keep rising ‘in near term’
Nonalcoholic fatty liver disease (NAFLD) almost tripled among United States veterans in a recent 9-year period, investigators reported.
From the AGA Journals
Nonalcoholic fatty liver disease linked to liver cancer without cirrhosis
About 13% of U.S. veterans with hepatocellular carcinoma had no evidence of preexisting cirrhosis, researchers reported in the January issue of...
News
Experts call for international cooperation on human gene editing
As the International Summit on Human Gene Editing comes to a close, organizers call for cooperation to establish norms for acceptable and ethical...
Conference Coverage
Roux-en-Y improves NASH in obese patients
Bariatric surgery is an effective treatment for nonalcoholic steatohepatitis (NASH) in obese patients, a Markov model suggests.